Noticias y Actividades de Aspira Women’s Health

Aspira Women’s Health es una empresa que cotiza bajo el símbolo de cotización AWH (US).

Ver el organigrama con sus 15 ejecutivos principales

Biografías más buscadas en Aspira Women’s Health

• Jack Fraser, Interim Chief Executive Officer and Chairman of the B...
• Jeffrey Cohen, Director
• Jane Wood, Director

Recientes movimientos de ejecutivos en Aspira Women’s Health

• Jack Fraser que ha sido Chairman of the Board, pasa a ser Interim Chief Executive Officer and Chairman of the Board  (noticia publicada el 23 de junio de 2026).
• Mike Buhle, Chief Executive Officer, ha dejado la empresa  (noticia publicada el 23 de junio de 2026).
• John Strahley, se ha incorporado a la empresa como Chief Financial Officer  (noticia publicada el 31 de mayo de 2026).

Crear su alerta
para seguir los movimientos de los ejecutivos en Aspira Women’s Health.

Aspira Women’s Health tiene 1.244 competidores entre los que se incluyen Thermo Fisher Scientific (Estados Unidos), Cytiva (Estados Unidos) y Philips (Países Bajos).

Popular M&A news in Equipos médicos

• Think Surgical acaba de anunciar una recaudación de fondos de 65 millones de dólares. (publicado el 16 de julio de 2026).
• Pearl Health acaba de anunciar una recaudación de fondos de 110 millones de dólares. (publicado el 12 de julio de 2026).
• EQT has announced the acquisition of Corza Medical  (publicado el 9 de julio de 2026).

Otros contactos sugeridos en el sector Equipos médicos

• Ivan Tornos - Chairman, President and Chief Executive Officer en Zimmer Biomet
• Kevin Lobo - President, Chief Executive Office & Chairman of the Board en Stryker
• Marc Casper - Chairman of the Board, President and Chief Executive Officer en Thermo Fisher Scientific

Saber más sobre el sector Equipos médicos

Últimos comunicados de prensa de Aspira Women’s Health

• Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® – Aspira Women's Health
• Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 – Aspira Women's Health
• Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health – Aspira Women's Health
• Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 – Aspira Women's Health
• Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch® – Aspira Women's Health
• Aspira Women’s Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass – Aspira Women's Health
• Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference – Aspira Women's Health
• View more press releases Close

Redes sociales sobre Aspira Women’s Health

• Aspira Women’s Health en Wikipedia, Google News y Yahoo Finance
• Aspira Women’s Health en LinkedIn, Twitter y YouTube